PIS
ELV icon

POM Investment Strategies’s Elevance Health ELV Stock Holding History

POM Investment Strategies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$1.74K – 174
2025
Q1 		$1.74K Sell
4
-13
-76% -$5.22K ﹤0.01% 165
2024
Q4 		$6.27K Buy
17
+13
+325% +$5.44K ﹤0.01% 203
2024
Q3 		$2.08K Hold
4
– – ﹤0.01% 228
2024
Q2 		$2.17K Hold
4
– – ﹤0.01% 271
2024
Q1 		$2.07K Hold
4
– – ﹤0.01% 192
2023
Q4 		$1.89K Buy
+4
New +$1.85K ﹤0.01% 187

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

POM Investment Strategies's ELV Position: Q2 2025 in Review

POM Investment Strategies sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 4 shares — an estimated $1.74K sold.

POM Investment Strategies first reported a position in ELV in Q4 2023 and held it in 6 quarters. The position peaked at $6.27K in Q4 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • POM Investment Strategies reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • POM Investment Strategies sold 4 Elevance Health shares in Q2 2025, an estimated $1.74K.
  • POM Investment Strategies first reported a position in Elevance Health in Q4 2023 and held it in 6 quarters.
  • POM Investment Strategies's Elevance Health position peaked at $6.27K in Q4 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on POM Investment Strategies's 13F filing for Q2 2025, filed 8 Aug 2025.